Heart of Health Policy | FDA Pilot Program to Address Improved Transparency of Drug Clinical Trial Data

U.S. Food and Drug Administration (FDA) Commissioner, Scott Gottlieb, MD, recently announced a new pilot program to improve transparency around clinical trial information to spur innovation and scientific analysis for new drugs.